P6238Predictive factors for alirocumab dose increase in...

P6238Predictive factors for alirocumab dose increase in patients with hypercholesterolaemia and high cardiovascular risk: from the ODYSSEY COMBO I and II trials

Vallejo-Vaz, A.J., Roth, E.M., Hovingh, G.K., Louie, M.J., Valcheva, V., Letierce, A., Ray, K.K.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
38
Language:
english
Journal:
European Heart Journal
DOI:
10.1093/eurheartj/ehx493.P6238
Date:
August, 2017
File:
PDF, 90 KB
english, 2017
Conversion to is in progress
Conversion to is failed